section name header

Information

Commonly Prescribed Drugs

See Mechanism of Action of Select Bronchodilators table.

 

Pharmacologic Profile

General Use

Used in the treatment of reversible airway obstruction due to asthma or chronic obstructive pulmonary disease. Rapid-acting inhaled beta-agonist bronchodilators (albuterol or levalbuterol) should be reserved as acute relievers of bronchospasm; repeated or chronic use indicates the need for additional long-term control agents, including inhaled corticosteroids, mast cell stabilizers, long-acting bronchodilators (oral theophylline, beta2 agonists, or anticholinergics), and leukotriene modifiers (montelukast, zafirlukast).


 

General Action and Information

MECHANISM OF ACTION OF SELECT BRONCHODILATORS
DRUGMECHANISM
Albuterol, epinephrine, formoterol, levalbuterol, terbutaline, and vilanterolBeta2 receptor agonists
Ipratropium and tiotropiumAnticholinergics

 

Contraindications

Hypersensitivity to agents or preservatives (bisulfites) used in their formulation. Avoid use in uncontrolled cardiac arrhythmias.


 

Precautions

Use beta2 agonists cautiously in patients with diabetes, cardiovascular disease, or hyperthyroidism. Use anticholinergic agents cautiously in narrow-angle glaucoma, prostatic hyperplasia, or bladder-neck obstruction.


 

Interactions

Therapeutic effectiveness of beta2 agonists may be antagonized by concurrent use of beta blockers. Beta2 agonists may have additive sympathomimetic effects with other adrenergic drugs, including vasopressors and decongestants. Use of anticholinergic agents with other agents with anticholinergic activity may result in additive anticholinergic effects (dry mouth, dry eyes, blurred vision, constipation).


 

Nursing Implications

Assessment

Implementation

Patient/Family Teaching

Evaluation/Desired Outcomes


Bronchodilators included in Davis's Drug Guide for Nurses